Adhesion receptor antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 413/06 (2006.01) A61K 31/496 (2006.01) A61P 9/10 (2006.01) C07D 413/14 (2006.01) C07D 211/34 (2006.01) C07D 263/20 (2006.01) C07D 295/15 (2006.01)

Patent

CA 2175767

Compounds of the formula I (see formula I) in which R1, R2 and R3 have the stated meanings, and their physiologically acceptable salts, inhibit the binding of fibrinogen to the corresponding receptor and can be used for the treatment of thromboses, osteoporoses, oncoses, stroke, myocardial infarct, ischemias, inflammations, arteriosclerosis and osteolytic disorders.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Adhesion receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adhesion receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adhesion receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1357193

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.